Medium impact
Pharmacy Codes Open for Billing
Nevada Medicaid·Effective Jun 1, 2026
HCPCS J7601 is officially defined as "Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg." HCPCS J7601 is referenced in 1 tracked payer policy change from Nevada Medicaid. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J7601 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.